Cargando…

Acute camptocormia induced by olanzapine: a case report

INTRODUCTION: Camptocormia refers to an abnormal posture with flexion of the thoraco-lumbar spine which increases during walking and resolves in supine position. This symptom is an increasingly recognized feature of parkinsonian and dystonic disorders, but may also be caused by neuromuscular disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Robert, Florence, Koenig, Martial, Robert, Aurélie, Boyer, Stéphane, Cathébras, Pascal, Camdessanché, Jean-Philippe
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904791/
https://www.ncbi.nlm.nih.gov/pubmed/20579377
http://dx.doi.org/10.1186/1752-1947-4-192
_version_ 1782183913139994624
author Robert, Florence
Koenig, Martial
Robert, Aurélie
Boyer, Stéphane
Cathébras, Pascal
Camdessanché, Jean-Philippe
author_facet Robert, Florence
Koenig, Martial
Robert, Aurélie
Boyer, Stéphane
Cathébras, Pascal
Camdessanché, Jean-Philippe
author_sort Robert, Florence
collection PubMed
description INTRODUCTION: Camptocormia refers to an abnormal posture with flexion of the thoraco-lumbar spine which increases during walking and resolves in supine position. This symptom is an increasingly recognized feature of parkinsonian and dystonic disorders, but may also be caused by neuromuscular diseases. There is recent evidence that both central and peripheral mechanisms may be involved in the pathogenesis of camptocormia. We report a case of acute onset of camptocormia, a rare side effect induced by olanzapine, a second-generation atypical anti-psychotic drug with fewer extra-pyramidal side-effects, increasingly used as first line therapy for schizophrenia, delusional disorders and bipolar disorder. CASE PRESENTATION: A 73-year-old Caucasian woman with no history of neuromuscular disorder, treated for chronic delusional disorder for the last ten years, received two injections of long-acting haloperidol. She was then referred for fatigue. Physical examination showed a frank parkinsonism without other abnormalities. Routine laboratory tests showed normal results, notably concerning creatine kinase level. Fatigue was attributed to haloperidol which was substituted for olanzapine. Our patient left the hospital after five days without complaint. She was admitted again three days later with acute back pain. Examination showed camptocormia and tenderness in paraspinal muscles. Creatine kinase level was elevated (2986 UI/L). Magnetic resonance imaging showed necrosis and edema in paraspinal muscles. Olanzapine was discontinued. Pain resolved quickly and muscle enzymes were normalized within ten days. Risperidone was later introduced without significant side-effect. The camptocormic posture had disappeared when the patient was seen as an out-patient one year later. CONCLUSIONS: Camptocormia is a heterogeneous syndrome of various causes. We believe that our case illustrates the need to search for paraspinal muscle damage, including drug-induced rhabdomyolysis, in patients presenting with acute-onset bent spine syndrome. Although rare, the occurrence of camptocormia induced by olanzapine must be considered.
format Text
id pubmed-2904791
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29047912010-07-16 Acute camptocormia induced by olanzapine: a case report Robert, Florence Koenig, Martial Robert, Aurélie Boyer, Stéphane Cathébras, Pascal Camdessanché, Jean-Philippe J Med Case Reports Case Report INTRODUCTION: Camptocormia refers to an abnormal posture with flexion of the thoraco-lumbar spine which increases during walking and resolves in supine position. This symptom is an increasingly recognized feature of parkinsonian and dystonic disorders, but may also be caused by neuromuscular diseases. There is recent evidence that both central and peripheral mechanisms may be involved in the pathogenesis of camptocormia. We report a case of acute onset of camptocormia, a rare side effect induced by olanzapine, a second-generation atypical anti-psychotic drug with fewer extra-pyramidal side-effects, increasingly used as first line therapy for schizophrenia, delusional disorders and bipolar disorder. CASE PRESENTATION: A 73-year-old Caucasian woman with no history of neuromuscular disorder, treated for chronic delusional disorder for the last ten years, received two injections of long-acting haloperidol. She was then referred for fatigue. Physical examination showed a frank parkinsonism without other abnormalities. Routine laboratory tests showed normal results, notably concerning creatine kinase level. Fatigue was attributed to haloperidol which was substituted for olanzapine. Our patient left the hospital after five days without complaint. She was admitted again three days later with acute back pain. Examination showed camptocormia and tenderness in paraspinal muscles. Creatine kinase level was elevated (2986 UI/L). Magnetic resonance imaging showed necrosis and edema in paraspinal muscles. Olanzapine was discontinued. Pain resolved quickly and muscle enzymes were normalized within ten days. Risperidone was later introduced without significant side-effect. The camptocormic posture had disappeared when the patient was seen as an out-patient one year later. CONCLUSIONS: Camptocormia is a heterogeneous syndrome of various causes. We believe that our case illustrates the need to search for paraspinal muscle damage, including drug-induced rhabdomyolysis, in patients presenting with acute-onset bent spine syndrome. Although rare, the occurrence of camptocormia induced by olanzapine must be considered. BioMed Central 2010-06-25 /pmc/articles/PMC2904791/ /pubmed/20579377 http://dx.doi.org/10.1186/1752-1947-4-192 Text en Copyright ©2010 Robert et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Robert, Florence
Koenig, Martial
Robert, Aurélie
Boyer, Stéphane
Cathébras, Pascal
Camdessanché, Jean-Philippe
Acute camptocormia induced by olanzapine: a case report
title Acute camptocormia induced by olanzapine: a case report
title_full Acute camptocormia induced by olanzapine: a case report
title_fullStr Acute camptocormia induced by olanzapine: a case report
title_full_unstemmed Acute camptocormia induced by olanzapine: a case report
title_short Acute camptocormia induced by olanzapine: a case report
title_sort acute camptocormia induced by olanzapine: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904791/
https://www.ncbi.nlm.nih.gov/pubmed/20579377
http://dx.doi.org/10.1186/1752-1947-4-192
work_keys_str_mv AT robertflorence acutecamptocormiainducedbyolanzapineacasereport
AT koenigmartial acutecamptocormiainducedbyolanzapineacasereport
AT robertaurelie acutecamptocormiainducedbyolanzapineacasereport
AT boyerstephane acutecamptocormiainducedbyolanzapineacasereport
AT cathebraspascal acutecamptocormiainducedbyolanzapineacasereport
AT camdessanchejeanphilippe acutecamptocormiainducedbyolanzapineacasereport